|
TODAY'S HEADLINES
The JAK inhibitor ruxolitinib has been shown to regrow hair in patients with alopecia areata, results of a small study suggest.
» Find out more
|
|
Researchers in Taiwan have identified genetic variants that are associated with severe adverse skin reactions to the drug phenytoin. » Read about risk factors
|
ADVERTISEMENT
Best practices in the evaluation and management of actinic keratoses
Articles, video, tools and CME on current strategies for managing actinic keratoses lesions using a variety of therapeutic approaches based on efficacy, safety and tolerability.
 Read More.
|
|
fyi...
|
$6 billion |
|
Potential healthcare cost savings by implementing telemedicine. Source: Towers Watson
|
|
|
Advanced basal cell carcinoma is a term whose frequency of usage has increased recently, in part due to the introduction of the Hedgehog pathway inhibitor vismodegib. Some estimates suggest that more than 3,000 deaths may be associated with advanced BCC each year in the United States. » See how to treat aBCC
|
|
The Food and Drug Administration has approved oritavancin, making it the third antibacterial drug approval this year for the treatment of acute skin infections. » See other approvals
|
|
|
Like
Tweet
